Driessen J, Kersten MJ, Visser L, van den Berg A, et al. Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP. Leukemia 2022 Oct 14. pii: 10.1038/s41375-022-01717.
PMID: 36241696